ASPM and endometrial cancer: Aberrant expression levels of four genes out of 12 core DEGs showed a significant (P < 0.05)association with poor prognosis of endometrial cancer, and this included two up-regulated (TOP2A and ASPM) and two down-regulated (FOXL2 and EFEMP1) genes (Fig. 6a–d).